Shenglei Zhang

507 total citations
43 papers, 348 citations indexed

About

Shenglei Zhang is a scholar working on Molecular Biology, Nephrology and Cancer Research. According to data from OpenAlex, Shenglei Zhang has authored 43 papers receiving a total of 348 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 13 papers in Nephrology and 11 papers in Cancer Research. Recurrent topics in Shenglei Zhang's work include Mitochondrial Function and Pathology (9 papers), MicroRNA in disease regulation (9 papers) and Parathyroid Disorders and Treatments (7 papers). Shenglei Zhang is often cited by papers focused on Mitochondrial Function and Pathology (9 papers), MicroRNA in disease regulation (9 papers) and Parathyroid Disorders and Treatments (7 papers). Shenglei Zhang collaborates with scholars based in China and United States. Shenglei Zhang's co-authors include Yaling Bai, Jinsheng Xu, Liwen Cui, Huiran Zhang, Zhanjun Guo, Jingjing Jin, Jinsheng Xu, Junxia Zhang, Junxia Zhang and Junxia Zhang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and The FASEB Journal.

In The Last Decade

Shenglei Zhang

36 papers receiving 344 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shenglei Zhang China 12 161 94 67 56 43 43 348
Jun Zou China 13 143 0.9× 138 1.5× 71 1.1× 32 0.6× 39 0.9× 27 400
Niki Prakoura France 13 171 1.1× 121 1.3× 62 0.9× 29 0.5× 54 1.3× 23 436
Sergio Berzal Spain 8 160 1.0× 147 1.6× 53 0.8× 43 0.8× 48 1.1× 8 375
Zhizhi Hu China 10 239 1.5× 120 1.3× 166 2.5× 119 2.1× 46 1.1× 16 468
Houyong Dai China 11 147 0.9× 107 1.1× 46 0.7× 26 0.5× 47 1.1× 20 342
Qiuju Wei China 12 130 0.8× 159 1.7× 76 1.1× 37 0.7× 58 1.3× 33 384
Kana Ide Japan 10 154 1.0× 72 0.8× 99 1.5× 57 1.0× 38 0.9× 14 298
Han-Seong Kim South Korea 9 111 0.7× 48 0.5× 62 0.9× 19 0.3× 72 1.7× 13 330
Annelies De Maré Belgium 8 162 1.0× 193 2.1× 41 0.6× 13 0.2× 45 1.0× 9 407

Countries citing papers authored by Shenglei Zhang

Since Specialization
Citations

This map shows the geographic impact of Shenglei Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shenglei Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shenglei Zhang more than expected).

Fields of papers citing papers by Shenglei Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shenglei Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shenglei Zhang. The network helps show where Shenglei Zhang may publish in the future.

Co-authorship network of co-authors of Shenglei Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Shenglei Zhang. A scholar is included among the top collaborators of Shenglei Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shenglei Zhang. Shenglei Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
4.
Jin, Jingjing, et al.. (2024). Circulating miR-129-3p in combination with clinical factors predicts vascular calcification in hemodialysis patients. Clinical Kidney Journal. 17(3). sfae038–sfae038. 2 indexed citations
5.
Bai, Yaling, et al.. (2024). Hypomethylation of the LncRNA H19 promoter accelerates osteogenic differentiation of vascular smooth muscle cells by activating the Erk1/2 pathways. Journal of International Medical Research. 52(3). 3649295495–3649295495. 2 indexed citations
6.
7.
Cui, Binbin, Mengjun Liu, Qing Li, et al.. (2022). Pharmacological inhibition of SMYD2 protects against cisplatin-induced acute kidney injury in mice. Frontiers in Pharmacology. 13. 829630–829630. 12 indexed citations
8.
Jin, Jingjing, et al.. (2022). DRAM1 plays a tumor suppressor role in clear cell renal cell carcinoma through modulating Akt signaling. Acta Histochemica. 124(3). 151874–151874. 1 indexed citations
9.
Liu, Feng, Binbin Cui, Yanfen Wu, et al.. (2021). Correlation of Serum Adropin Levels with Risk Factors of Cardiovascular Disease in Hemodialysis Patients. Metabolic Syndrome and Related Disorders. 19(7). 401–408. 9 indexed citations
10.
11.
Bai, Yaling, Jingjing Jin, Wei Zhou, Shenglei Zhang, & Jinsheng Xu. (2021). The safety outcomes of sodium-glucose cotransporter 2 inhibitors in patients with different renal function: A systematic review and meta-analysis. Nutrition Metabolism and Cardiovascular Diseases. 31(5). 1365–1374. 14 indexed citations
12.
Liu, Xinying, et al.. (2020). Identification of a genome-wide serum microRNA expression profile as potential noninvasive biomarkers for chronic kidney disease using next-generation sequencing. Journal of International Medical Research. 48(12). 1220769033–1220769033. 10 indexed citations
13.
Zhao, Man, Shenglei Zhang, Zhibin Xu, et al.. (2020). Effects of tumor distance from anal verge on survival outcomes for rectal NENs and lymphatic metastasis risk score for colorectal NENs. International Journal of Colorectal Disease. 35(7). 1255–1264. 7 indexed citations
14.
Xu, Jinsheng, et al.. (2019). Meta-Analysis of the Association between Fibroblast Growth Factor 23 and Mortality and Cardiovascular Events in Hemodialysis Patients. Blood Purification. 47(Suppl. 1). 24–30. 18 indexed citations
15.
Wang, Hongfang, Jinsheng Xu, Demao Li, Shenglei Zhang, & Zhanjun Guo. (2017). Identification of sequence polymorphisms in the mitochondrial cytochrome c oxidase genes as risk factors for hepatocellular carcinoma. Journal of Clinical Laboratory Analysis. 32(3). 8 indexed citations
16.
Cui, Liwen, Yaling Bai, Jinsheng Xu, et al.. (2015). Single-nucleotide polymorphism of the UMOD promoter is associated with the outcome of chronic kidney disease patients. Biomedical Reports. 3(4). 588–592. 4 indexed citations
17.
Bai, Yaling, Junxia Zhang, Jinsheng Xu, et al.. (2015). Magnesium prevents β-glycerophosphate-induced calcification in rat aortic vascular smooth muscle cells. Biomedical Reports. 3(4). 593–597. 31 indexed citations
18.
Bai, Yaling, Junxia Zhang, Jinsheng Xu, et al.. (2015). Alteration of Type I Collagen in the Radial Artery of Patients With End-Stage Renal Disease. The American Journal of the Medical Sciences. 349(4). 292–297. 10 indexed citations
19.
Xu, Jinsheng, Zhanjun Guo, Yaling Bai, et al.. (2014). Single nucleotide polymorphisms in the D-loop region of mitochondrial DNA is associated with the kidney survival time in chronic kidney disease patients. Renal Failure. 37(1). 108–112. 9 indexed citations
20.
Zhang, Junxia, Zhanjun Guo, Yaling Bai, et al.. (2013). Identification of sequence polymorphisms in the displacement loop region of mitochondrial DNA as a risk factor for renal cell carcinoma. Biomedical Reports. 1(4). 563–566. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jun Zou Breakdown of academic impact, for papers by Niki Prakoura Breakdown of academic impact, for papers by Sergio Berzal Breakdown of academic impact, for papers by Zhizhi Hu Breakdown of academic impact, for papers by Houyong Dai Breakdown of academic impact, for papers by Qiuju Wei Breakdown of academic impact, for papers by Kana Ide Breakdown of academic impact, for papers by Han-Seong Kim Breakdown of academic impact, for papers by Annelies De Maré
Rankless by CCL
2026